Back to search
Phase II study with paclitaxel for the treatment of advanced inoperable non-small cell lung cancer
Data up to Jan 2025
Published1995
Citations46
References6
Total Citations Per Year
Abstract
References (6)
Taxol: A Unique Antineoplastic Agent with Significant Activity in Advanced Ovarian Epithelial Neoplasms
1989 • 1,111 citations
THE IMPACT OF NATIONAL CANCER ACT
1991 • 809 citations
Phase II Trial of Taxol, an Active Drug in the Treatment of Metastatic Breast Cancer
1991 • 730 citations
Phase II Study of Taxol in Patients With Untreated Advanced Non-Small-Cell Lung Cancer
1993 • 441 citations
Phase II Study of Taxol, Merbarone, and Piroxantrone in Stage IV Non-Small-Cell Lung Cancer: The Eastern Cooperative Oncology Group Results
1993 • 346 citations
Preliminary evaluation of a multicenter, randomized comparative study of TAXOL (paclitaxel) dose and infusion length in platinum-treated ovarian cancer
1993 • 35 citations
Cited By (0)
Loading...